These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26537270)

  • 21. The metabolic consequences of overweight in a cohort of children with type 1 diabetes.
    Sevaliev N; Strich D; Avnon-Ziv C; Levy-Khademi F
    J Pediatr Endocrinol Metab; 2019 Jul; 32(7):715-719. PubMed ID: 31150359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey.
    Pajunen P; Kotronen A; Korpi-Hyövälti E; Keinänen-Kiukaanniemi S; Oksa H; Niskanen L; Saaristo T; Saltevo JT; Sundvall J; Vanhala M; Uusitupa M; Peltonen M
    BMC Public Health; 2011 Oct; 11():754. PubMed ID: 21962038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of premorbid metabolic syndrome in Spanish adult workers using IDF and ATPIII diagnostic criteria: relationship with cardiovascular risk factors.
    Tauler P; Bennasar-Veny M; Morales-Asencio JM; Lopez-Gonzalez AA; Vicente-Herrero T; De Pedro-Gomez J; Royo V; Pericas-Beltran J; Aguilo A
    PLoS One; 2014; 9(2):e89281. PubMed ID: 24586656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sugar intake in Sudanese individuals was associated with some features of the metabolic syndrome: Population based study.
    El-Sayed EF; Awadalla H; Noor SK; Elmadhoun WM; Sulaiman AA; Almobarak AO; Ahmed MH
    Diabetes Metab Syndr; 2018 May; 12(3):245-250. PubMed ID: 29050917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leisure-time physical activity, sedentary behaviors, sleep, and cardiometabolic risk factors at baseline in the PREDIMED-PLUS intervention trial: A cross-sectional analysis.
    Rosique-Esteban N; Díaz-López A; Martínez-González MA; Corella D; Goday A; Martínez JA; Romaguera D; Vioque J; Arós F; Garcia-Rios A; Tinahones F; Estruch R; Fernández-García JC; Lapetra J; Serra-Majem L; Pinto X; Tur JA; Bueno-Cavanillas A; Vidal J; Delgado-Rodríguez M; Daimiel L; Vázquez C; Rubio MÁ; Ros E; Salas-Salvadó J;
    PLoS One; 2017; 12(3):e0172253. PubMed ID: 28273154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and prevalence of metabolic syndrome among overweight and obese young Palestinian students at An-Najah National University.
    Damiri B; Aghbar A; Alkhdour S; Arafat Y
    Diabetes Metab Syndr; 2018 May; 12(3):343-348. PubMed ID: 29306543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body size phenotypes and inflammation in the Women's Health Initiative Observational Study.
    Wildman RP; Kaplan R; Manson JE; Rajkovic A; Connelly SA; Mackey RH; Tinker LF; Curb JD; Eaton CB; Wassertheil-Smoller S
    Obesity (Silver Spring); 2011 Jul; 19(7):1482-91. PubMed ID: 21233809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health and mortality consequences of abdominal obesity: evidence from the AusDiab study.
    Cameron AJ; Dunstan DW; Owen N; Zimmet PZ; Barr EL; Tonkin AM; Magliano DJ; Murray SG; Welborn TA; Shaw JE
    Med J Aust; 2009 Aug; 191(4):202-8. PubMed ID: 19705980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men.
    Arnlöv J; Sundström J; Ingelsson E; Lind L
    Diabetes Care; 2011 Jan; 34(1):61-5. PubMed ID: 20852030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic Syndrome: Prevalence and Risk Factors among Adolescent Female Intermediate and Secondary Students in Saudi Arabia.
    Alowfi A; Binladen S; Irqsous S; Khashoggi A; Khan MA; Calacattawi R
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33671739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of metabolic syndrome among patients attending diabetes clinics in two sub-urban hospitals: Bono Region, Ghana.
    Abagre TA; Bandoh DA; Addo-Lartey AA
    BMC Cardiovasc Disord; 2022 Aug; 22(1):366. PubMed ID: 35948874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial.
    Masmiquel L; Leiter LA; Vidal J; Bain S; Petrie J; Franek E; Raz I; Comlekci A; Jacob S; van Gaal L; Baeres FM; Marso SP; Eriksson M;
    Cardiovasc Diabetol; 2016 Feb; 15():29. PubMed ID: 26864124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study.
    Baldassarre S; Fragapani S; Panero A; Fedele D; Pinach S; Lucchiari M; Vitale AR; Mengozzi G; Gruden G; Bruno G
    Cardiovasc Diabetol; 2017 Sep; 16(1):119. PubMed ID: 28946871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of overweight, obesity and metabolic syndrome components in children, adolescents and young adults with type 1 diabetes mellitus.
    Pinhas-Hamiel O; Levek-Motola N; Kaidar K; Boyko V; Tisch E; Mazor-Aronovitch K; Graf-Barel C; Landau Z; Lerner-Geva L; Frumkin Ben-David R
    Diabetes Metab Res Rev; 2015 Jan; 31(1):76-84. PubMed ID: 24827815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome.
    Forlani G; Di Bonito P; Mannucci E; Capaldo B; Genovese S; Orrasch M; Scaldaferri L; Di Bartolo P; Melandri P; Dei Cas A; Zavaroni I; Marchesini G
    J Endocrinol Invest; 2008 Feb; 31(2):146-52. PubMed ID: 18362506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey.
    Sanisoglu SY; Oktenli C; Hasimi A; Yokusoglu M; Ugurlu M
    BMC Public Health; 2006 Apr; 6():92. PubMed ID: 16606462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
    Fingeret M; Marques-Vidal P; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of insulin resistance and cardiometabolic risk in Korean children and adolescents: a population-based study.
    Yi KH; Hwang JS; Kim EY; Lee SH; Kim DH; Lim JS
    Diabetes Res Clin Pract; 2014 Jan; 103(1):106-13. PubMed ID: 24290751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.